10.1371/journal.pone.0153696.t004
Tat Ming Ng
Tat Ming
Ng
Wendy X. Khong
Wendy X.
Khong
Patrick N. A. Harris
Patrick N. A.
Harris
Partha P. De
Partha P.
De
Angela Chow
Angela
Chow
Paul A. Tambyah
Paul
A. Tambyah
David C. Lye
David
C. Lye
A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.
Public Library of Science
2016
propensity score
empiric monotherapy
risk factors
mortality
Limited data
empiric carbapenem therapy
multivariate analysis
CI
ESBL
Klebsiella pneumoniae bacteraemia
394 patients
2016-04-22 06:20:39
Dataset
https://plos.figshare.com/articles/dataset/A_propensity_score_for_receiving_carbapenem_adjusted_multivariable_analysis_of_30_day_relapse_bacteraemia_for_101_patients_with_ESBL_producing_i_E_i_i_coli_i_and_i_K_i_i_pneumoniae_i_bacteraemia_receiving_either_empiric_piperacllin_tazobactam_or_carbapene/3197638
<p>A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.</p>